Prebiotics in Patients With Type 1 Diabetes
Abroad (travel likely)Recruiting
Conditions
Type 1 Diabetes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Calgary, Calgary, Alberta, Canada
University of Alberta, Edmonton, Alberta, Canada
Contact: Study coordinator (Elizabeth Rosolowsky, MD, MPH) · Elizabeth.Rosolowsky@albertahealthservices.ca · 780-248-5483Contact: Principal Investigator (Elizabeth Rosolowsky, MD, MPH)University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Contact: Principal Investigator (Munier Nour, MD, MSc)
Study leads
Raylene A Reimer, PhD, RD
Principal Investigator
University of Calgary